Human African trypanosomiasis: an emerging public health crisis

被引:0
|
作者
Smith, DH
Pepin, J
Stich, AHR
机构
[1] Univ Liverpool, Liverpool Sch Trop Med, Div Trop Med, Liverpool L3 5QA, Merseyside, England
[2] Univ Sherbrooke, Fac Med, Sherbrooke, PQ, Canada
[3] Inst Wurzburg, Med Mission, Wurzburg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a dramatic resurgence of human African trypanosomiasis (HAT) in sub-Saharan Africa. T.b. gambiense is spreading epidemically in large areas of Central Africa, especially the Southern Sudan, Congo-Zaire, Angola, Uganda and the Central African Republic. Devastating epidemics of T.b. rhodesiense have occurred in south-eastern Uganda. The causes of the re-emergence of sleeping sickness as a public health problem include widespread civil disturbance and war, declining economies, reduced health financing and the dismantling of disease control programmes. Despite the inevitably fatal outcome without treatment, HAT is often given low priority by donors and national governments. The advances made in diagnosis, treatment and vector control have not been sufficiently implemented. To limit the human impact in some of the poorest communities in Africa, endemic countries will require external support to implement strategies for disease control. Donor agencies, NGOs and mission organisations could play an important role in supporting control efforts. National authorities will need to control and co-ordinate these efforts with assistance from WHO and the international community.
引用
收藏
页码:341 / 355
页数:15
相关论文
共 50 条
  • [31] THE PUBLIC-HEALTH IMPORTANCE OF AFRICAN TRYPANOSOMIASIS IN NORTH-EAST ZAMBIA
    WURAPA, FK
    BULSARA, MK
    CHEN, MG
    WYATT, GB
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1984, 36 (04): : 329 - 333
  • [32] Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership
    Bernhard, Sonja
    Kaiser, Marcel
    Burri, Christian
    Maeser, Pascal
    DISEASES, 2022, 10 (04)
  • [33] The evolving spectrum of human African trypanosomiasis
    Kennedy, P. G. E.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2023, 117 (06) : 391 - 395
  • [34] Human African trypanosomiasis:: Epidemiology and control
    Fevre, E. M.
    Picozzi, K.
    Jannin, J.
    Welburn, S. C.
    Maudlin, I.
    ADVANCES IN PARASITOLOGY, VOL 61: CONTROL OF HUMAN PARASITIC DISEASES, 2006, 61 : 167 - +
  • [35] Treatment and control of human African trypanosomiasis
    Jannin, J
    Cattand, P
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) : 565 - 570
  • [36] Eflornithine for the treatment of human African trypanosomiasis
    Christian Burri
    Reto Brun
    Parasitology Research, 2003, 90 : S49 - S52
  • [37] Human African trypanosomiasis in travellers to Kenya
    Gobbi, F.
    Bisoffi, Z.
    EUROSURVEILLANCE, 2012, 17 (10): : 2 - 4
  • [38] New candidate for human African trypanosomiasis
    不详
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (10) : 1240 - 1240
  • [39] HEMIPLEGIC FORMS OF HUMAN AFRICAN TRYPANOSOMIASIS
    SONAN, T
    GIORDANO, C
    BOA, F
    DUMAS, M
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1988, 81 (3BIS): : 459 - 463
  • [40] Towards the Atlas of human African trypanosomiasis
    Cecchi, Giuliano
    Paone, Massimo
    Franco, Jose R.
    Fevre, Eric M.
    Diarra, Abdoulaye
    Ruiz, Jose A.
    Mattioli, Raffaele C.
    Simarro, Pere P.
    INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS, 2009, 8